475 related articles for article (PubMed ID: 29277243)
1. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
3. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer.
Lu YJ; Wang P; Peng J; Wang X; Zhu YW; Shen N
Sci Rep; 2017 Apr; 7(1):905. PubMed ID: 28424486
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis.
Groot Koerkamp B; Rahbari NN; Büchler MW; Koch M; Weitz J
Ann Surg Oncol; 2013 Jul; 20(7):2156-65. PubMed ID: 23456317
[TBL] [Abstract][Full Text] [Related]
7. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.
Wang S; Du H; Li G
Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
Lu G; Lu Z; Li C; Huang X; Luo Q
Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
[TBL] [Abstract][Full Text] [Related]
9. The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis.
Lu YJ; Wang P; Wang X; Peng J; Zhu YW; Shen N
Oncotarget; 2016 Jun; 7(24):37361-37369. PubMed ID: 27008698
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.
Rahbari NN; Aigner M; Thorlund K; Mollberg N; Motschall E; Jensen K; Diener MK; Büchler MW; Koch M; Weitz J
Gastroenterology; 2010 May; 138(5):1714-26. PubMed ID: 20100481
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
12. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
Jiang H; Gu X; Zuo Z; Tian G; Liu J
PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.
Bork U; Rahbari NN; Schölch S; Reissfelder C; Kahlert C; Büchler MW; Weitz J; Koch M
Br J Cancer; 2015 Apr; 112(8):1306-13. PubMed ID: 25867263
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Fan JL; Yang YF; Yuan CH; Chen H; Wang FB
Cell Physiol Biochem; 2015; 37(2):629-40. PubMed ID: 26344495
[TBL] [Abstract][Full Text] [Related]
18. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
Yu J; Yang M; Peng T; Liu Y; Cao Y
Sci Rep; 2023 Nov; 13(1):18791. PubMed ID: 37914786
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
Abdalla TSA; Meiners J; Riethdorf S; König A; Melling N; Gorges T; Karstens KF; Izbicki JR; Pantel K; Reeh M
PLoS One; 2021; 16(6):e0252897. PubMed ID: 34111181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
